Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know
WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its...
1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Avoid
1 Cash-Producing Stock Worth Your Attention and 2 We Avoid
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
1 High-Flying Stock with Solid Fundamentals and 2 We Avoid
1 Cash-Heavy Stock to Target This Week and 2 We Question
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
2 Growth Stocks Set to Flourishand 1 We Turn Down
3 Profitable Stocks We Keep Off Our Radar